Spineway (FRA:37S) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:37S Spineway FRA:37S
48 GF Score
Price €0.13
GF Value €199.88
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Spineway Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:37S
48GF Score
Spineway FRA:37S
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Spineway (FRA:37S) Overvalued in 2026?

Based on GuruFocus' analysis, Spineway stock appears to be undervalued. The current stock price of €0.13 is trading 99.9% below its estimated GF Value™ of €199.88. GuruFocus considers Spineway to be Possible Value Trap.

Key valuation signals for FRA:37S:

  • Dividends Received:
  • GF Value™: €199.88 vs. price of €0.13 (99.9% below fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the FRA:37S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Spineway Business Description

Other Exchanges ALSPW:France
Address 7 Allee Moulin Berger, Ecully, FRA, 69130
Spineway designs produce and markets implant lines and ancillary surgical equipment used for the treatment of severe disorders of the spinal column. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, and other such medical instruments.
48GF Score

Get the complete analysis for FRA:37S

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.13
Price
€199.88
GF Value